Kairos Pharma to Present Investor Update at H.C. Wainwright Conference
Kairos Pharma issued a new investor presentation and will present an update on its clinical program at the H.C. Wainwright conference.Key Highlights:Original SEC Filing: Kairos Pharma, LTD. [ KAPA ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.